HIKAL
Back to Balance Sheet
|
HIKAL Last 5 Year Deferred Tax Assets / Liabilities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Deferred Tax Assets / Liabilities | ₹33 Cr | ₹30 Cr | ₹33 Cr | ₹36 Cr | ₹38 Cr |
What is the latest Deferred Tax Assets / Liabilities ratio of HIKAL ?
| Year | Deferred Tax Assets / Liabilities |
|---|---|
| Mar2025 | ₹33 Cr |
| Mar2024 | ₹30 Cr |
| Mar2023 | ₹33 Cr |
| Mar2022 | ₹36 Cr |
| Mar2021 | ₹38 Cr |
How is Deferred Tax Assets / Liabilities of HIKAL Trending?
| Years | Deferred Tax Assets / Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹33 Cr | 8.33 | |
| Mar2024 | ₹30 Cr | -8.30 | |
| Mar2023 | ₹33 Cr | -10.14 | |
| Mar2022 | ₹36 Cr | -3.13 | |
| Mar2021 | ₹38 Cr | - | |
Compare Deferred Tax Assets / Liabilities of peers of HIKAL
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| HIKAL | ₹2,096.7 Cr | -6.6% | -21.9% | -53.6% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹430,825.0 Cr | -1.7% | 4% | 11.8% | Stock Analytics | |
| DIVIS LABORATORIES | ₹161,535.0 Cr | -4.7% | -1.8% | 10.1% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹145,733.0 Cr | -3.7% | 4.5% | 42.9% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹107,094.0 Cr | -3% | 0% | 15.4% | Stock Analytics | |
| CIPLA | ₹103,513.0 Cr | -2.6% | -2.3% | -10.1% | Stock Analytics | |
HIKAL Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| HIKAL | -6.6% |
-21.9% |
-53.6% |
| SENSEX | -2.7% |
-9.1% |
2.6% |
You may also like the below Video Courses